Effect of rimonabant on progression of atherosclerosis in patients with abdominal obesity and coronary artery disease: the STRADIVARIUS randomized controlled trial.
第一作者:
Steven E,Nissen
第一单位:
Department of Cardiovascular Medicine and Cleveland Clinic Lerner School of Medicine, Cleveland, Ohio, USA. nissens@ccf.org
作者:
主题词
老年人(Aged);动脉粥样硬化(Atherosclerosis);冠状动脉疾病(Coronary Artery Disease);冠状血管(Coronary Vessels);膳食, 减重(Diet, Reducing);疾病恶化(Disease Progression);双盲法(Double-Blind Method);女(雌)性(Female);人类(Humans);男(雄)性(Male);中年人(Middle Aged);肥胖症(Obesity);哌啶类(Piperidines);前瞻性研究(Prospective Studies);吡唑类(Pyrazoles);受体, 大麻酚, CB1(Receptor, Cannabinoid, CB1);超声检查, 介入性(Ultrasonography, Interventional)
DOI
10.1001/jama.299.13.1547
PMID
18387931
发布时间
2022-03-21
- 浏览50

JAMA
1547-60页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文